Jane Street Group, LLC Biogen Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $14.1 Million - $17.6 Million	74,500 New	74,500 $14.4 Million
Q1 2022 May 17, 2022	SELL	$193.77 - $244.14 $14.9 Million - $18.8 Million	-77,100 Reduced 24.28%	240,500 $50.6 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $36 Million - $46.3 Million	-160,900 Reduced 33.63%	317,600 $76.2 Million
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $49.2 Million - $64.2 Million	-173,900 Reduced 26.66%	478,500 $135 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $88.9 Million - $142 Million	343,400 Added 111.13%	652,400 $226 Million
Q1 2021 May 18, 2021	BUY	$242.95 - $284.63 $9.21 Million - $10.8 Million	37,900 Added 13.98%	309,000 $86.4 Million
Q4 2020 Feb 17, 2021	SELL	$236.26 - $355.63 $496,146 - $746,823	-2,100 Reduced 0.77%	271,100 $66.4 Million
Q3 2020 Nov 17, 2020	BUY	$264.77 - $305.71 $9.45 Million - $10.9 Million	35,700 Added 15.03%	273,200 $77.5 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $21.8 Million - $28.9 Million	84,400 Added 55.13%	237,500 $63.5 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $25.1 Million - $31.8 Million	93,200 Added 155.59%	153,100 $48.4 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $5.94 Million - $8.21 Million	-27,000 Reduced 31.07%	59,900 $17.8 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.15 Million - $2.41 Million	9,900 Added 12.86%	86,900 $20.2 Million
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $21.6 Million - $23.9 Million	-98,700 Reduced 56.18%	77,000 $18 Million
Q1 2019 May 16, 2019	BUY	$216.71 - $338.96 $31.1 Million - $48.6 Million	143,400 Added 443.96%	175,700 $41.5 Million
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $779,800 - $987,700	2,800 Added 9.49%	32,300 $9.72 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $821,828 - $1.07 Million	-2,800 Reduced 8.67%	29,500 $10.4 Million
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $5.23 Million - $6.23 Million	-20,300 Reduced 38.59%	32,300 $9.38 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $6.3 Million - $8.9 Million	24,200 Added 85.21%	52,600 $14.4 Million
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $10.6 Million - $11.8 Million	-34,300 Reduced 54.7%	28,400 $9.05 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $17.6 Million - $20.7 Million	62,700	62,700 $19.6 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account